Skip to main content
SAMSUNG BIOLOGICS CO.,LTD. logo

SAMSUNG BIOLOGICS CO.,LTD. — Investor Relations & Filings

Ticker · 207940 ISIN · KR7207940008 KO Manufacturing
Open in API
Filings indexed 762 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country KR South Korea
Listing KO 207940

About SAMSUNG BIOLOGICS CO.,LTD.

https://samsungbiologics.com/

Samsung Biologics is a fully integrated contract development and manufacturing organization (CDMO) that provides end-to-end services to the biopharmaceutical industry. The company offers a comprehensive suite of solutions covering the entire product lifecycle, from early-stage cell line and process development to large-scale commercial manufacturing of drug substances. Key services include analytical development, quality and biosafety testing, and aseptic fill/finish of drug products. Samsung Biologics also supports the development and manufacturing of new modalities, including antibody-drug conjugates (ADCs) and mRNA. Leveraging its large-scale, CGMP-compliant facilities, the company serves a global client base of pharmaceutical companies with tailored and flexible manufacturing solutions.

Recent filings

Filing Released Lang Actions
최대주주등소유주식변동신고서
Regulatory Filings
2026-05-04 Korean
동일인등출자계열회사와의상품ㆍ용역거래변경
Regulatory Filings Classification · 1% confidence The document is a Korean regulatory announcement detailing changes in goods and services transactions between Samsung Biologics and its affiliated companies under the Fair Trade Act. It does not represent an annual or interim financial report, earnings release, AGM materials, or any other specific category like M&A or dividends. It is a routine compliance disclosure of related‐party transactions, which falls under miscellaneous regulatory filings. Therefore, it is classified as a general Regulatory Filing (RNS).
2026-04-24 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 1% confidence The document is a public disclosure of consolidated provisional operating results for Q1 2026, providing headline figures for revenue, operating profit, pre-tax income, and net profit compared to prior periods. It is clearly an initial summary of quarterly financial performance (잠정실적), not a full interim report or annual filing. This matches the definition of an Earnings Release. Q1 2026
2026-04-22 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 1% confidence The document is a Korean regulatory disclosure detailing a correction and full text of a single sales and supply contract (contract amount change at customer’s request) by Samsung Biologics. It contains contract terms, dates, amounts, and reasons for amendment. It is not an annual report, earnings release, board change, financing announcement, M&A, share issuance, dividend notice, etc. It does not present a proxy solicitation or ESG report. This type of business contract announcement does not correspond to any specialized category listed, so it falls under the fallback “Regulatory Filings” category (RNS).
2026-04-10 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 1% confidence The document is an advance notice (“예고(안내공시)”) of the upcoming quarterly financial results announcement (period ending March 31, 2026) and states the date when the full report will be published on the company website. It does not contain the actual financial results but merely announces the timing of the report’s publication. This matches the definition of a Report Publication Announcement (RPA).
2026-04-08 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 1% confidence The document is a Korean ‘최대주주등 소유주식변동신고서’ (report on changes in shareholding by major shareholders), detailing changes in the share counts and ownership percentages for the largest shareholders and affiliates. This is a regulatory disclosure of major shareholding movements, matching the definition for Major Shareholding Notification (MRQ).
2026-04-06 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.